[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-338137-105":59,"doc-detail-338137-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","apoptosis-and-cuproptosis-co-activated-copper-based-metal-organic-frameworks-for-cancer-therapy","Apoptosis and cuproptosis Co-activated Copper-based metal-organic frameworks for cancer therapy","","Lung cancer, especially KRAS-mutated non-small cell lung cancer (NSCLC), faces limited treatment options. A copper-based metal-organic framework (Cu-MOF) is developed as a cuproptosis-mediated nanoplatform that disassembles in the lysosomal acidic microenvironment to release copper ions. Copper triggers Fenton chemistry, producing hydroxyl radicals that cause oxidative injury, cytoskeletal disruption, caspase-3 activation, and apoptosis. Through FDX1 mediation, copper binding to DLAT disrupts iron-sulfur proteins and induces aggregation of lipoylated proteins, culminating in proteotoxic stress-induced cuproptosis. Strong anti-tumor efficacy appears in vitro and in vivo, supporting dual apoptosis/cuproptosis therapy for NSCLC and broader Cu-based nanomaterial potential.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/apoptosis-and-cuproptosis-co-activated-copper-based-metal-organic-frameworks-for-cancer-therapy/338137/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/apoptosis-and-cuproptosis-co-activated-copper-based-metal-organic-frameworks-for-cancer-therapy/338137.png","ImageObject",300,407,{"name":92,"@type":93},"Theodore","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-01","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What problem does the study target in lung cancer therapy?","Question",{"text":113,"@type":114},"The study targets KRAS-mutated NSCLC, where therapeutic options remain limited and patients often show resistance to current approaches.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How does the Cu-MOF nanoplatform induce apoptosis?",{"text":118,"@type":114},"Cu-MOF disassembles in the acidic lysosomal environment, releasing copper ions that catalyze the Fenton reaction. This generates hydroxyl radicals, leading to oxidative damage, cytoskeletal disruption, and caspase-3 activation, which triggers apoptosis.",{"name":120,"@type":111,"acceptedAnswer":121},"How is cuproptosis induced in this work?",{"text":122,"@type":114},"With FDX1 mediation, copper ions bind the mitochondrial protein DLAT, causing loss of iron-sulfur cluster proteins and aggregation of lipoylated proteins. These changes create proteotoxic stress that culminates in cuproptosis.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},338137,1790194373,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":105,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},7971461740886,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","Li etal. Journal of Nanobiotechnology (2024) 22:546  \n[https://doi.org/10.1186/s12951-024-02828-3](https://doi.org/10.1186/s12951-024-02828-3)  \nJournal of Nanobiotechnology  \nRESEARCH Open Access  \nApoptosis and cuproptosis Co-activated Copper-based metal-organic frameworks for cancer therapy  \nKun Li 1†, Leilei Wu2†, Han Wang3, Zi Fu3, Jiani Gao 1, Xiucheng Liu 1, Yongfei Fan 1, Xichun Qin 1, Dalong Ni3,4*, Jing Wang5* and Dong Xie 1*  \nAbstract  \nLung cancer, predominantly non-small cell lung cancer (NSCLC), remains a significant global health challenge, with limited therapeutic options for patients with KRAS-mutated tumors. Herein, a copper-based metal-organic framework (Cu-MOF) was applied as a novel cuproptosis-mediated nanoplatform for lung cancer therapy. CuMOF would disassemble and liberate copper ions under the acidic microenvironment of lysosomes of cancer cells, initiating a cascade of cellular events. The released copper ions catalyzes the Fenton reaction, generating hydroxyl radicals that induce oxidative damage, leading to cytoskeletal disruption and activation of caspase-3, ultimately triggering apoptosis. Simultaneously, with the mediation of the key regulatory factor FDX1, we found that the copper ions binding to the mitochondrial protein DLAT could result in the loss of iron-sulfur cluster proteins and aggregation of lipoylated proteins, which culminated in proteotoxic stress-induced cuproptosis. The pronounced anti-tumor effects of Cu-MOF with apoptosis and cuproptosis were confirmed both in vitro and in vivo experiments. Such dual induction of apoptosis and cuproptosis by Cu-MOF presents a promising therapeutic strategy for NSCLC, particularly for KRAS-mutated tumors, and expands potential applications of Cu-based nanomateirals for other cancers.  \nKeywords Cuproptosis, Apoptosis, Cytoskeletal structure, Metal-organic frameworks, Nanomedicine  \n†Kun Li and Leilei Wu contributed equally to this work.  \n*Correspondence:  \nDalong Ni[ndl12353@rjh.com.cn](ndl12353@rjh.com.cn)  \nJing Wang [jingwang1114@tongji.edu.cn](jingwang1114@tongji.edu.cn)[ ](jingwang1114@tongji.edu.cn)Dong Xie [xiedong@tongji.edu.cn](xiedong@tongji.edu.cn)  \n1Department of Thoracic Surgery, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai 200433, P. R. China  \n2Department of Thoracic Surgery, Hangzhou Institute of Medicine (HIM), Zhejiang Cancer Hospital, Chinese Academy of Sciences,  \nHangzhou 310005, P. R. China  \n3Department of Orthopaedics, Shanghai Key Laboratory for Prevention and Treatment of Bone and Joint Diseases, Shanghai Institute of Traumatology and Orthopaedics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, P. R. China  \n4Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Science, Suzhou 215163, P. R. China  \n5Department of Radiology, Shanghai Fourth People’s Hospital, School of Medicine, Tongji University, Shanghai 200434, P. R. China  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/l](http://creativecommons.org/l)icenses/by/4.0/.  \nLi et al. Journal of Nanobiotechnology (2024) 22:546  \nIntroduction  \nLung cancer is the second most common c","cbCaidlvrwRg7Gp1","https://ap.wps.com/l/cbCaidlvrwRg7Gp1","pdf",9695066,"English","# Introduction\n## Cuproptosis and mitochondria-targeting copper strategies\n# Abstract\n## Dual apoptosis and cuproptosis mechanism\n# Keywords","[{\"question\":\"What problem does the study target in lung cancer therapy?\",\"answer\":\"The study targets KRAS-mutated NSCLC, where therapeutic options remain limited and patients often show resistance to current approaches.\"},{\"question\":\"How does the Cu-MOF nanoplatform induce apoptosis?\",\"answer\":\"Cu-MOF disassembles in the acidic lysosomal environment, releasing copper ions that catalyze the Fenton reaction. This generates hydroxyl radicals, leading to oxidative damage, cytoskeletal disruption, and caspase-3 activation, which triggers apoptosis.\"},{\"question\":\"How is cuproptosis induced in this work?\",\"answer\":\"With FDX1 mediation, copper ions bind the mitochondrial protein DLAT, causing loss of iron-sulfur cluster proteins and aggregation of lipoylated proteins. These changes create proteotoxic stress that culminates in cuproptosis.\"}]","Apoptosis and cuproptosis Co-activated Copper-based metal-organic frameworks for cancer therapy | PDF",1790022131,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/57c1b0033766eafeaddd0acdbbec9a95.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c945fe1b3d4501616795be830ff4dbcb.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cff064a2d9d794dc9333e79c8c198448.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2509dbcf213ca9194580ab77da3be62d.webp",980,1306]